Back
 IJCM  Vol.4 No.7 , July 2013
Sporadic Creutzfeldt-Jakob Disease Presenting with Visual Disturbance—A Case Report in China
Abstract: Creutzfeldt-Jakob disease (CJD) is a rare but fatal neurodegenerative prion disease. Classic CJD comprises a clinical triad of rapidly progressive dementia, myoclonus, and EEG abnormality. At initial presentation, this classic triad is present only in a minority of cases. Visual impairment is one of the predominant manifestations in the course of CJD, especially in Heidenhain variant phenotype. We reported a case presenting with progressive blurred vision, along with other neurological symptoms, who diagnosed as sporadic CJD with cortical blindness in China.

Cite this paper: G. Tian, L. Sun, Y. He and X. Zhang, "Sporadic Creutzfeldt-Jakob Disease Presenting with Visual Disturbance—A Case Report in China," International Journal of Clinical Medicine, Vol. 4 No. 7, 2013, pp. 321-324. doi: 10.4236/ijcm.2013.47057.
References

[1]   A. Ladogana, M. Puopolo, E. A. Croes, H. Budka, et al., “Mortality from Creutzfeldt-Jakob Disease and Related Disorders in Europe, Australia, and Canada,” Neurology, Vol. 64, No. 9, 2005, pp. 1586-1591. doi:10.1212/01.WNL.0000160117.56690.B2

[2]   C. Gao, Q. Shi, C. Tian, C. Chen, J. Han, W. Zhou, B. Y. Zhang, H. Y. Jiang, J. Zhang and X. P. Dong, “The Epidemiological, Clinical, and Laboratory Features of Sporadic Creutzfeldt-Jakob Disease Patients in China: Surveillance Data from 2006 to 2010,” PLoS One, Vol. 6, No. 8, 2011, Article ID: e24231. doi:10.1371/journal.pone.0024231

[3]   E. Eggenberger, “Prion Disease,” Neurologic Clinics, Vol. 25, No. 3, 2007, pp. 833-842. doi:10.1016/j.ncl.2007.03.006

[4]   S. Kropp, W. J. Schulz-Schaeffer, M. Finkenstaedt, et al., “The Heidenhain Variant of Creutzfeldt-Jakob Disease,” Archives of Neurology, Vol. 56, No. 1, 1999, pp. 55-61. doi:10.1001/archneur.56.1.55

[5]   S. A. Cooper, K. L. Murray, C. A. Heath, R. G. Will and R. S. Knight, “Isolated Visual Symptoms at Onset in Sporadic Creutzfeldt-Jakob Disease: The Clinical Phenotype of the ‘Heidenhain Variant’,” British Journal of Ophthalmology, Vol. 89, No. 10, 2005, pp. 1341-1342. doi:10.1136/bjo.2005.074856

[6]   A. A. Proulx, M. J. Strong and D. A. Nicolle, “Creutzfeldt-Jakob Disease Presenting with Visual Manifestations,” Canadian Journal of Ophthalmology, Vol. 43, No. 5, 2008, pp. 591-595. doi:10.3129/I08-123

[7]   R. W. Paterson, C. C. Torres-Chae, A. L. Kuo, T. Ando, E. A. Nguyen, K. Wong, S. J. Dearmond, A. Haman, P. Garcia, D. Y. Johnson, B. L. Miller and M. D. Geschwind, “Differential Diagnosis of Jakob-Creutzfeldt Disease,” Archives of Neurology, Vol. 24, 2012, pp. 1-5.

[8]   T. Muayqil, G. Gronseth and R. Camicioli, “EvidenceBased Guideline: Diagnostic Accuracy of CSF 14-3-3 Protein in Sporadic Creutzfeldt-Jakob Disease: Report of the Guideline Development Subcommittee of the American Academy of Neurology,” Neurology, Vol. 79, No. 14, 2012, pp. 1499-1506. doi:10.1212/WNL.0b013e31826d5fc3

[9]   P. Vitali, E. Maccagnano, E. Caverzasi, R. G. Henry, A. Haman, C. Torres-Chae, D. Y. Johnson, B. L. Miller and M. D. Geschwind, “Diffusion-Weighted MRI Hyperintensity Patterns Differentiate CJD from Other Rapid Dementias,” Neurology, Vol. 76, No. 20, 2011, pp. 17111719. doi:10.1212/WNL.0b013e31821a4439

[10]   S. Prasad, E. B. Lee, J. H. Woo, A. Alavi and S. L. Galetta, “Photo Essay. MRI and Positron Emission Tomography Findings in Heidenhain Variant CreutzfeldtJakob Disease,” Journal of Neuro-Ophthalmology, Vol. 30, No. 3, 2010, pp. 260-262. doi:10.1097/WNO.0b013e3181e2aef7

 
 
Top